| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 17914-41-9 | Actinomycin C2a(8CI,9CI); ActinomycinD, 2B-D-alloisoleucine-; 1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, cyclic peptidederiv.; 3H-Phenoxazine, cyclic peptide deriv.; 3H-Phenoxazine-1,9-dicarboxamide,2-amino-N1-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-; Actinomycin Ay2 |  | C63H88N12O16 | 詳情 | 供應商 | |
| 28526-45-6 | Actinomycin Au7b(8CI,9CI); ActinomycinD, 2A-D-leucine-5A-(N-methyl-D-valine)-5B-(N-methyl-D-valine)-; 1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, actinomycin D deriv.; 3H-Phenoxazine, actinomycin D deriv.; 3H-Phenoxazine-1,9-dicarboxamide,2-amino-N9-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N1-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(2-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo- |  | C63H88N12O16 | 詳情 | 供應商 | |
| 27888-11-5 | Actinomycin Au7a(8CI,9CI); ActinomycinD, 2B-D-leucine-5A-(N-methyl-D-valine)-5B-(N-methyl-D-valine)-; 1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, actinomycin D deriv.; 3H-Phenoxazine, actinomycin D deriv.; 3H-Phenoxazine-1,9-dicarboxamide,2-amino-N1-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(2-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo- |  | C63H88N12O16 | 詳情 | 供應商 | |
| 2612-14-8 | Actinomycin D,2A-D-alloisoleucine-; ActinomycinC2 (6CI,7CI,8CI,9CI); 1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine,cyclic peptide deriv.; 3H-Phenoxazine, actinomycin D deriv.; 3H-Phenoxazine-1,9-dicarboxamide,2-amino-N9-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N1-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-; NSC 87221 |  | C63H88N12O16 | 詳情 | 供應商 |